» Articles » PMID: 17656888

A Clinical Study of Vitiligo

Overview
Date 2007 Jul 28
PMID 17656888
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

A clinical study of one hundred patients having vitiligo revealed the incidence among new patients to be 1.84%. The male/female ratio was 1:1.22. Family history of vitiligo was available in 8% of our patients. The different morphological pattern consisted of vitiligo vulgaris (39 cases), focal vitiligo (27 cases), acrofacial vitiligo (18 cases), lip-tip vitiligo (7 cases), lip vitiligo (5 cases), segmental vitiligo (3 cases) and universal vitiligo (1 case). Associated diseases include atopic dermatitis (2 cases), Hansen's disease (2 cases), alopecia areata (1 case), halo naevus (1 case), chronic urticaria (1 case), lichen planus (1 case), diabetes mellitus (9 cases), hypertension (4 cases), hypothyroidism (2 cases), epilepsy (1 case) and IHD (1 case).

Citing Articles

Study to evaluate effect of oral mini pulse corticosteroid therapy for unstable vitiligo on hypothalamic pituitary adrenal axis suppression.

Sinha P, Sood A, Mukherjee B, Sinha A, Baveja S, Pathania V Med J Armed Forces India. 2024; 80(Suppl 1):S66-S72.

PMID: 39734899 PMC: 11670551. DOI: 10.1016/j.mjafi.2022.08.010.


Risk factors for cardiovascular diseases in patients with vitiligo: an analysis of current evidence.

Liang X, Guo F, Zhang M, Wang C, Lin N, Liu L Ann Med. 2024; 56(1):2326297.

PMID: 39300810 PMC: 11418058. DOI: 10.1080/07853890.2024.2326297.


Clinico-Epidemiological Profile of Vitiligo Among Patients Attending a Tertiary Care Centre of North-East India.

Saha D, Roy S, Ahmed R, Mahanta Sr P Cureus. 2024; 16(4):e58804.

PMID: 38784306 PMC: 11112533. DOI: 10.7759/cureus.58804.


Apremilast Add-On Benefits Over Conventional Drugs (ABCD) in Unstable Non-segmental Vitiligo: A 12-Week Single-Center Randomized Controlled Trial.

Sharma S, Bhardwaj A, Dwivedi P, Yadav S, Shamim M, Singh S Cureus. 2023; 15(4):e37180.

PMID: 37153322 PMC: 10162885. DOI: 10.7759/cureus.37180.


Novel immunological and genetic factors associated with vitiligo: A review.

Said-Fernandez S, Sanchez-Dominguez C, Salinas-Santander M, Martinez-Rodriguez H, Kubelis-Lopez D, Zapata-Salazar N Exp Ther Med. 2021; 21(4):312.

PMID: 33717255 PMC: 7885061. DOI: 10.3892/etm.2021.9743.